[HTML][HTML] Update: influenza activity—United States, October 2, 2016–February 4, 2017
L Blanton - MMWR. Morbidity and mortality weekly report, 2017 - cdc.gov
L Blanton
MMWR. Morbidity and mortality weekly report, 2017•cdc.govInfluenza activity in the United States began to increase in mid-December, remained
elevated through February 4, 2016, and is expected to continue for several more weeks.
During October 2, 2016–February 4, 2017, influenza A (H3N2) viruses were identified most
frequently, but influenza A (H1N1) pdm09 and influenza B viruses were also reported. No
antiviral resistance to oseltamivir, zanamivir, or peramivir has been identified among
influenza viruses tested to date.
elevated through February 4, 2016, and is expected to continue for several more weeks.
During October 2, 2016–February 4, 2017, influenza A (H3N2) viruses were identified most
frequently, but influenza A (H1N1) pdm09 and influenza B viruses were also reported. No
antiviral resistance to oseltamivir, zanamivir, or peramivir has been identified among
influenza viruses tested to date.
Influenza activity in the United States began to increase in mid-December, remained elevated through February 4, 2016, and is expected to continue for several more weeks. During October 2, 2016–February 4, 2017, influenza A (H3N2) viruses were identified most frequently, but influenza A (H1N1) pdm09 and influenza B viruses were also reported. No antiviral resistance to oseltamivir, zanamivir, or peramivir has been identified among influenza viruses tested to date.
cdc.gov